Publications by authors named "Philippe Bellity"
Background: Most facelift techniques have limited effect on the nasolabial fold and the more medial part of the face. The facial rejuvenation enhancing cheek (FRENCH) lift can treat both jowl sagging and midface deflation by a monobloc vertical and oblique displacement of the anterior column of the face through an extended subcutaneous dissection.
Objectives: To explain the surgical technique and to show its efficacy on the nasolabial fold, jawline and infraorbital rim.
Supported by recent literature on the signs of aging of the middle and lower face, our clinical research has documented a loss of volume of the deep structural components of the central face and a progressive descent of the nasolabial fat and the jowl fat, leading to facial fragmentation. The signs that appear around the age of 45 to 50 years are well targeted by the mini-invasive technique described here. We focused on refitting the jowl fat and the nasolabial fat associated with cutaneous tightening.
View Article and Find Full Text PDFArticle Synopsis
- A survey in France evaluated the use of onabotulinumtoxin A (a type of Botox) for treating aging in the lower face and neck.
- The study involved 57 participants reviewing techniques, resulting in recommendations that address specific facial concerns and techniques for effective treatment.
- The findings indicate that using onabotulinumtoxin A, often alongside other treatments, can lead to natural-looking results and better understanding of facial aging.
Background: Onabotulinumtoxin A (onabotulinum) has been used for 7 years in the treatment of the aging face. A survey was conducted to identify current practices in France.
Objective: To develop consensual practice recommendations for treating the aging upper- and mid-face with onabotulinum.